Abstract
A large number of different mutations in the p53 tumor suppressor gene have been identified in all types of cancer. As of October, 1997, this database (http:// perso.curie.fr/tsoussi ) contained >7500 mutations. Such a substantial increase since our previous reports should enable epidemiological analyses which were not previously possible. In order to analyse these new data, the UMD software has been improved. A new Web version of the UMD software enables online analysis of the database. The present report describes various improvements since the last release of the database.
Full Text
The Full Text of this article is available as a PDF (697.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergh J., Norberg T., Sjögren S., Lindgren A., Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1995 Oct;1(10):1029–1034. doi: 10.1038/nm1095-1029. [DOI] [PubMed] [Google Scholar]
- Brash D. E., Rudolph J. A., Simon J. A., Lin A., McKenna G. J., Baden H. P., Halperin A. J., Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124–10128. doi: 10.1073/pnas.88.22.10124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Béroud C., Verdier F., Soussi T. p53 gene mutation: software and database. Nucleic Acids Res. 1996 Jan 1;24(1):147–150. doi: 10.1093/nar/24.1.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Børresen A. L., Andersen T. I., Eyfjörd J. E., Cornelis R. S., Thorlacius S., Borg A., Johansson U., Theillet C., Scherneck S., Hartman S. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer. 1995 Sep;14(1):71–75. doi: 10.1002/gcc.2870140113. [DOI] [PubMed] [Google Scholar]
- Cariello N. F., Cui L., Beroud C., Soussi T. Database and software for the analysis of mutations in the human p53 gene. Cancer Res. 1994 Aug 15;54(16):4454–4460. [PubMed] [Google Scholar]
- Caron de Fromentel C., Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992 Jan;4(1):1–15. doi: 10.1002/gcc.2870040102. [DOI] [PubMed] [Google Scholar]
- Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994 Jul 15;265(5170):346–355. doi: 10.1126/science.8023157. [DOI] [PubMed] [Google Scholar]
- Collod G., Béroud C., Soussi T., Junien C., Boileau C. Software and database for the analysis of mutations in the human FBN1 gene. Nucleic Acids Res. 1996 Jan 1;24(1):137–140. doi: 10.1093/nar/24.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dumaz N., Stary A., Soussi T., Daya-Grosjean L., Sarasin A. Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutat Res. 1994 May 1;307(1):375–386. doi: 10.1016/0027-5107(94)90311-5. [DOI] [PubMed] [Google Scholar]
- Friedlander P., Haupt Y., Prives C., Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol Cell Biol. 1996 Sep;16(9):4961–4971. doi: 10.1128/mcb.16.9.4961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goh H. S., Yao J., Smith D. R. p53 point mutation and survival in colorectal cancer patients. Cancer Res. 1995 Nov 15;55(22):5217–5221. [PubMed] [Google Scholar]
- Greenblatt M. S., Grollman A. P., Harris C. C. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model. Cancer Res. 1996 May 1;56(9):2130–2136. [PubMed] [Google Scholar]
- Laurent-Puig P., Béroud C., Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1998 Jan 1;26(1):269–270. doi: 10.1093/nar/26.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Laurent-Puig P., Béroud C., Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1998 Jan 1;26(1):269–270. doi: 10.1093/nar/26.1.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ory K., Legros Y., Auguin C., Soussi T. Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J. 1994 Aug 1;13(15):3496–3504. doi: 10.1002/j.1460-2075.1994.tb06656.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pontén F., Berg C., Ahmadian A., Ren Z. P., Nistér M., Lundeberg J., Uhlén M., Pontén J. Molecular pathology in basal cell cancer with p53 as a genetic marker. Oncogene. 1997 Aug 28;15(9):1059–1067. doi: 10.1038/sj.onc.1201435. [DOI] [PubMed] [Google Scholar]
- Rowan S., Ludwig R. L., Haupt Y., Bates S., Lu X., Oren M., Vousden K. H. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. EMBO J. 1996 Feb 15;15(4):827–838. [PMC free article] [PubMed] [Google Scholar]
- Varret M., Rabès J. P., Collod-Béroud G., Junien C., Boileau C., Béroud C. Software and database for the analysis of mutations in the human LDL receptor gene. Nucleic Acids Res. 1997 Jan 1;25(1):172–180. doi: 10.1093/nar/25.1.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varret M., Rabés J. P., Thiart R., Kotze M. J., Baron H., Cenarro A., Descamps O., Ebhardt M., Hondelijn J. C., Kostner G. M. LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis. Nucleic Acids Res. 1998 Jan 1;26(1):248–252. doi: 10.1093/nar/26.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]